Radiofrequency Treatment of Phantom and Residual Limb Pain in Persons with a Lower Limb Amputation: A Randomised Double Blinded Control Trial
- Conditions
- Phantom and Residual Limb Pain in Persons with a Lower Limb AmputationAnaesthesiology - Pain managementPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitation
- Registration Number
- ACTRN12613000549729
- Lead Sponsor
- The Royal Melbourne Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion criteria will be age >18, at least 1 major amputation above the ankle, the presence of persistent residual limb or phantom limb pain for at least 3 months with a peripheral trigger clinically +/- ultrasound (US) confirmation
Exclusion criteria are previous radiofrequency denervation of neuroma, contraindications to steroid, local anaesthetic and sedative agent administration, bleeding dyscrasias, immunosuppression, concomitant active infection of the procedure site or systemic infection, fragile residual limb skin prone to non-healing and breakdown, and severe cognitive impairment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression Anxiety Stress Scale (DASS)[1 week, 4 weeks, 12 weeks post intervention];Trinity Amputation and Prosthesis Experience Scale-Revised (TAPES-R)[1 week, 4 weeks, 12 weeks post intervention];Brief Pain Inventory (BPI) including Verbal Numerical Rating Score (VNRS) [1 week, 4 weeks, 12 weeks post intervention]
- Secondary Outcome Measures
Name Time Method The Patient Global Expression of Pain (PGIC) Scale[1 week, 4 weeks, 12 weeks post intervention];Short-Form MacGill Pain Questionnaire [1 week, 4 weeks, 12 weeks post intervention];Healthcare Utilisation (Information about medical attendance/s will be asked and recorded) [1 week, 4 weeks, 12 weeks post intervention]
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.